{"id":"https://openalex.org/W2896776930","doi":"https://doi.org/10.1017/s1092852918001086","title":"Successful switching of patients with acute schizophrenia from another antipsychotic to brexpiprazole: comparison of clinicians\u2019 choice of cross-titration schedules in a post hoc analysis of a randomized, double-blind, maintenance treatment study","display_name":"Successful switching of patients with acute schizophrenia from another antipsychotic to brexpiprazole: comparison of clinicians\u2019 choice of cross-titration schedules in a post hoc analysis of a randomized, double-blind, maintenance treatment study","publication_year":2018,"publication_date":"2018-10-11","ids":{"openalex":"https://openalex.org/W2896776930","doi":"https://doi.org/10.1017/s1092852918001086","mag":"2896776930","pmid":"https://pubmed.ncbi.nlm.nih.gov/30306884"},"language":"en","primary_location":{"id":"doi:10.1017/s1092852918001086","doi":"https://doi.org/10.1017/s1092852918001086","is_oa":true,"landing_page_url":"https://doi.org/10.1017/s1092852918001086","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/BB6FD769D14A48860C9840FD8424A4E4/S1092852918001086a.pdf/div-class-title-successful-switching-of-patients-with-acute-schizophrenia-from-another-antipsychotic-to-brexpiprazole-comparison-of-clinicians-choice-of-cross-titration-schedules-in-a-post-hoc-analysis-of-a-randomized-double-blind-maintenance-treatment-study-div.pdf","source":{"id":"https://openalex.org/S4210237982","display_name":"CNS Spectrums","issn_l":"1092-8529","issn":["1092-8529","2165-6509"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS Spectrums","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/BB6FD769D14A48860C9840FD8424A4E4/S1092852918001086a.pdf/div-class-title-successful-switching-of-patients-with-acute-schizophrenia-from-another-antipsychotic-to-brexpiprazole-comparison-of-clinicians-choice-of-cross-titration-schedules-in-a-post-hoc-analysis-of-a-randomized-double-blind-maintenance-treatment-study-div.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056944189","display_name":"Christoph Ulrich Correll","orcid":"https://orcid.org/0000-0002-7254-5646","observed_orcids":["https://orcid.org/0000-0002-7254-5646","https://orcid.org/0000-0002-0868-4449"]},"institutions":[{"id":"https://openalex.org/I1302444339","display_name":"Northwell Health","ror":"https://ror.org/02bxt4m23","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1302444339"]},{"id":"https://openalex.org/I139290212","display_name":"Hofstra University","ror":"https://ror.org/03pm18j10","country_code":"US","type":"education","lineage":["https://openalex.org/I139290212"]},{"id":"https://openalex.org/I4210106353","display_name":"Donald & Barbara Zucker School of Medicine at Hofstra/Northwell","ror":"https://ror.org/01ff5td15","country_code":"US","type":"education","lineage":["https://openalex.org/I1302444339","https://openalex.org/I139290212","https://openalex.org/I4210106353"]},{"id":"https://openalex.org/I4210166545","display_name":"Zucker Hillside Hospital","ror":"https://ror.org/05vh9vp33","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1302444339","https://openalex.org/I4210166545"]},{"id":"https://openalex.org/I7877124","display_name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","ror":"https://ror.org/001w7jn25","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I7877124"]}],"countries":["DE","US"],"is_corresponding":true,"raw_author_name":"Christoph U. Correll","raw_affiliation_strings":["Department of Psychiatry and Molecular Medicine, Hofstra Northwell School of Medicine, Hempstead, New York; and Recognition and Prevention (RAP) Program, Zucker Hillside Hospital, Northwell Health, Glen Oaks, New York; Charit\u00e9 Universit\u00e4tsmedizin, Department of Child and Adolescent Psychiatry, Berlin, Germany","Charit\u00e9 Universit\u00e4tsmedizin, Department of Child and Adolescent Psychiatry, Berlin, Germany","Department of Psychiatry and Molecular Medicine, Hofstra Northwell School of Medicine, Hempstead, New York","Recognition and Prevention (RAP) Program, Zucker Hillside Hospital, Northwell Health, Glen Oaks, New York"],"raw_orcid":"https://orcid.org/0000-0002-7254-5646","affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Molecular Medicine, Hofstra Northwell School of Medicine, Hempstead, New York; and Recognition and Prevention (RAP) Program, Zucker Hillside Hospital, Northwell Health, Glen Oaks, New York; Charit\u00e9 Universit\u00e4tsmedizin, Department of Child and Adolescent Psychiatry, Berlin, Germany","institution_ids":["https://openalex.org/I1302444339","https://openalex.org/I139290212","https://openalex.org/I4210106353","https://openalex.org/I4210166545","https://openalex.org/I7877124"]},{"raw_affiliation_string":"Charit\u00e9 Universit\u00e4tsmedizin, Department of Child and Adolescent Psychiatry, Berlin, Germany","institution_ids":["https://openalex.org/I7877124"]},{"raw_affiliation_string":"Department of Psychiatry and Molecular Medicine, Hofstra Northwell School of Medicine, Hempstead, New York","institution_ids":["https://openalex.org/I139290212"]},{"raw_affiliation_string":"Recognition and Prevention (RAP) Program, Zucker Hillside Hospital, Northwell Health, Glen Oaks, New York","institution_ids":["https://openalex.org/I1302444339","https://openalex.org/I4210166545"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110850987","display_name":"Lily Shi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086062","display_name":"Otsuka (United States)","ror":"https://ror.org/00ew4na22","country_code":"US","type":"company","lineage":["https://openalex.org/I114030911","https://openalex.org/I4210086062"]},{"id":"https://openalex.org/I4405268153","display_name":"Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)","ror":"https://ror.org/001nxvg84","country_code":"US","type":"company","lineage":["https://openalex.org/I4405268153"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lily Shi","raw_affiliation_strings":["Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, New Jersey","institution_ids":["https://openalex.org/I4210086062","https://openalex.org/I4405268153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032296107","display_name":"Catherine Weiss","orcid":"https://orcid.org/0000-0001-6712-4620","observed_orcids":["https://orcid.org/0000-0001-6712-4620"]},"institutions":[{"id":"https://openalex.org/I4210086062","display_name":"Otsuka (United States)","ror":"https://ror.org/00ew4na22","country_code":"US","type":"company","lineage":["https://openalex.org/I114030911","https://openalex.org/I4210086062"]},{"id":"https://openalex.org/I4405268153","display_name":"Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)","ror":"https://ror.org/001nxvg84","country_code":"US","type":"company","lineage":["https://openalex.org/I4405268153"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Catherine Weiss","raw_affiliation_strings":["Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, New Jersey","institution_ids":["https://openalex.org/I4210086062","https://openalex.org/I4405268153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110533970","display_name":"Mary Hobart","orcid":"https://orcid.org/0009-0006-0216-1483","observed_orcids":["https://orcid.org/0009-0006-0216-1483"]},"institutions":[{"id":"https://openalex.org/I4210086062","display_name":"Otsuka (United States)","ror":"https://ror.org/00ew4na22","country_code":"US","type":"company","lineage":["https://openalex.org/I114030911","https://openalex.org/I4210086062"]},{"id":"https://openalex.org/I4405268153","display_name":"Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)","ror":"https://ror.org/001nxvg84","country_code":"US","type":"company","lineage":["https://openalex.org/I4405268153"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mary Hobart","raw_affiliation_strings":["Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, New Jersey","institution_ids":["https://openalex.org/I4210086062","https://openalex.org/I4405268153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042720237","display_name":"Anna Eramo","orcid":"https://orcid.org/0000-0002-4289-0975","observed_orcids":["https://orcid.org/0000-0002-4289-0975"]},"institutions":[{"id":"https://openalex.org/I4210150391","display_name":"Lundbeck (United States)","ror":"https://ror.org/04a2yjk98","country_code":"US","type":"company","lineage":["https://openalex.org/I133593841","https://openalex.org/I4210150391"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anna Eramo","raw_affiliation_strings":["Lundbeck LLC, Deerfield, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lundbeck LLC, Deerfield, Illinois","institution_ids":["https://openalex.org/I4210150391"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042305916","display_name":"Ruth A. Duffy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086062","display_name":"Otsuka (United States)","ror":"https://ror.org/00ew4na22","country_code":"US","type":"company","lineage":["https://openalex.org/I114030911","https://openalex.org/I4210086062"]},{"id":"https://openalex.org/I4405268153","display_name":"Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)","ror":"https://ror.org/001nxvg84","country_code":"US","type":"company","lineage":["https://openalex.org/I4405268153"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ruth A. Duffy","raw_affiliation_strings":["Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, New Jersey","institution_ids":["https://openalex.org/I4210086062","https://openalex.org/I4405268153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110608128","display_name":"Emmanuelle Weiller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I133593841","display_name":"Lundbeck (Denmark)","ror":"https://ror.org/0564cd633","country_code":"DK","type":"company","lineage":["https://openalex.org/I133593841"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Emmanuelle Weiller","raw_affiliation_strings":["H. Lundbeck A/S, Valby, Copenhagen, Denmark(at the time of this work)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lundbeck A/S, Valby, Copenhagen, Denmark(at the time of this work)","institution_ids":["https://openalex.org/I133593841"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071947762","display_name":"Ross A. Baker","orcid":"https://orcid.org/0000-0001-5256-0470","observed_orcids":["https://orcid.org/0000-0001-5256-0470"]},"institutions":[{"id":"https://openalex.org/I4210086062","display_name":"Otsuka (United States)","ror":"https://ror.org/00ew4na22","country_code":"US","type":"company","lineage":["https://openalex.org/I114030911","https://openalex.org/I4210086062"]},{"id":"https://openalex.org/I4405268153","display_name":"Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)","ror":"https://ror.org/001nxvg84","country_code":"US","type":"company","lineage":["https://openalex.org/I4405268153"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ross A. Baker","raw_affiliation_strings":["Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, New Jersey","institution_ids":["https://openalex.org/I4210086062","https://openalex.org/I4405268153"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":9,"corresponding_author_ids":["https://openalex.org/A5056944189"],"corresponding_institution_ids":["https://openalex.org/I1302444339","https://openalex.org/I139290212","https://openalex.org/I4210106353","https://openalex.org/I4210166545","https://openalex.org/I7877124"],"apc_list":{"value":3550,"currency":"USD","value_usd":3550},"apc_paid":{"value":3550,"currency":"USD","value_usd":3550},"fwci":1.7875,"has_fulltext":true,"cited_by_count":16,"citation_normalized_percentile":{"value":0.82907876,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"24","issue":"5","first_page":"507","last_page":"517"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/brexpiprazole","display_name":"brexpiprazole","score":0.9259999990463257},{"id":"https://openalex.org/keywords/acute-schizophrenia","display_name":"acute schizophrenia","score":0.8479999899864197},{"id":"https://openalex.org/keywords/antipsychotic-switching","display_name":"antipsychotic switching","score":0.9509999752044678},{"id":"https://openalex.org/keywords/treatment-emergent-adverse-events","display_name":"treatment-emergent adverse events","score":0.8659999966621399},{"id":"https://openalex.org/keywords/discontinuation-rate","display_name":"discontinuation rate","score":0.6930000185966492},{"id":"https://openalex.org/keywords/positive-and-negative-syndrome-scale","display_name":"PANSS","score":0.652999997138977},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.3479999899864197}],"concepts":[{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8967387676239014},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.8413881063461304},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6115602850914001},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.5352628231048584},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.533903956413269},{"id":"https://openalex.org/C2780135775","wikidata":"https://www.wikidata.org/wiki/Q7233251","display_name":"Positive and Negative Syndrome Scale","level":3,"score":0.4285493791103363},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.4203470051288605},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38092243671417236},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.223261296749115},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.14686211943626404}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1017/s1092852918001086","doi":"https://doi.org/10.1017/s1092852918001086","is_oa":true,"landing_page_url":"https://doi.org/10.1017/s1092852918001086","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/BB6FD769D14A48860C9840FD8424A4E4/S1092852918001086a.pdf/div-class-title-successful-switching-of-patients-with-acute-schizophrenia-from-another-antipsychotic-to-brexpiprazole-comparison-of-clinicians-choice-of-cross-titration-schedules-in-a-post-hoc-analysis-of-a-randomized-double-blind-maintenance-treatment-study-div.pdf","source":{"id":"https://openalex.org/S4210237982","display_name":"CNS Spectrums","issn_l":"1092-8529","issn":["1092-8529","2165-6509"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS Spectrums","raw_type":"journal-article"},{"id":"pmid:30306884","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30306884","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS spectrums","raw_type":"Comparative Study"}],"best_oa_location":{"id":"doi:10.1017/s1092852918001086","doi":"https://doi.org/10.1017/s1092852918001086","is_oa":true,"landing_page_url":"https://doi.org/10.1017/s1092852918001086","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/BB6FD769D14A48860C9840FD8424A4E4/S1092852918001086a.pdf/div-class-title-successful-switching-of-patients-with-acute-schizophrenia-from-another-antipsychotic-to-brexpiprazole-comparison-of-clinicians-choice-of-cross-titration-schedules-in-a-post-hoc-analysis-of-a-randomized-double-blind-maintenance-treatment-study-div.pdf","source":{"id":"https://openalex.org/S4210237982","display_name":"CNS Spectrums","issn_l":"1092-8529","issn":["1092-8529","2165-6509"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS Spectrums","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320324177","display_name":"Otsuka Pharmaceutical","ror":"https://ror.org/013k5y296"},{"id":"https://openalex.org/F4320327918","display_name":"H. Lundbeck A/S","ror":"https://ror.org/0564cd633"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2896776930.pdf","grobid_xml":"https://content.openalex.org/works/W2896776930.grobid-xml"},"referenced_works_count":21,"referenced_works":["https://openalex.org/W21713058","https://openalex.org/W1578850691","https://openalex.org/W1979291291","https://openalex.org/W1990121386","https://openalex.org/W2026000778","https://openalex.org/W2039052522","https://openalex.org/W2067763161","https://openalex.org/W2119501809","https://openalex.org/W2120893202","https://openalex.org/W2140606211","https://openalex.org/W2151839057","https://openalex.org/W2162630389","https://openalex.org/W2410577948","https://openalex.org/W2513889801","https://openalex.org/W2527103551","https://openalex.org/W2562347285","https://openalex.org/W2588344078","https://openalex.org/W2592870337","https://openalex.org/W2746596746","https://openalex.org/W3090293687","https://openalex.org/W3171411502"],"related_works":["https://openalex.org/W3016634708","https://openalex.org/W4391117386","https://openalex.org/W2015871706","https://openalex.org/W2892670095","https://openalex.org/W7160280077","https://openalex.org/W2095457710","https://openalex.org/W4382918975","https://openalex.org/W4291001807","https://openalex.org/W2120893202","https://openalex.org/W3003638832"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"compare":[2],"the":[3,55,61,85,91,98,118,186],"tolerability":[4],"and":[5,70,73,124,140],"efficacy":[6,71,107],"of":[7,57,106,128,157,188,206,215],"different":[8],"antipsychotic":[9],"cross-titration":[10],"schedules,":[11],"using":[12],"data":[13,222],"from":[14,26,201],"a":[15,33,41,213,231],"brexpiprazole":[16,30,43,129,135,211],"study":[17],"(Equator;":[18],"NCT01668797).":[19],"METHODS:":[20],"Patients":[21,46],"with":[22,89,181],"schizophrenia":[23],"were":[24,47,78,111,132,142,208],"cross-titrated":[25,209],"other":[27,173],"antipsychotics":[28],"to":[29,54,104,134,210,229],"monotherapy":[31],"in":[32,60,97,113,172,197],"1-4":[34],"week":[35],"open-label":[36],"conversion":[37,62,81,99,115,174,183,192],"phase,":[38],"then":[39],"entered":[40],"single-blind":[42],"treatment":[44],"phase.":[45,63,100],"stratified":[48],"into":[49],"four":[50],"\"conversion":[51],"groups,\"":[52],"according":[53],"amount":[56],"time":[58],"spent":[59,94],"Discontinuation":[64,101],"rates,":[65],"treatment-emergent":[66],"adverse":[67,109],"events":[68,110],"(TEAEs),":[69],"(Positive":[72],"Negative":[74],"Syndrome":[75],"Scale":[76],"[PANSS])":[77],"compared":[79],"between":[80],"groups.":[82,116],"RESULTS:":[83],"Of":[84,117],"404":[86],"patients":[87,120,207],"treated":[88],"brexpiprazole,":[90],"majority":[92,205],"(72.0%)":[93],"22-33":[95,137,168,216],"days":[96,138,146,149,153,169],"rates":[102],"due":[103],"lack":[105],"or":[108,151],"low":[112,178],"all":[114],"292":[119],"who":[121],"successfully":[122],"switched":[123],"completed":[125],"8":[126,160],"weeks":[127,161],"treatment,":[130],"most":[131],"converted":[133,143,166],"over":[136,144,159,167,212],"(80.1%),":[139],"fewer":[141],"1-7":[145],"(2.4%),":[147],"8-14":[148],"(6.5%),":[150],"15-21":[152],"(11.0%).":[154],"The":[155,204],"incidence":[156],"TEAEs":[158],"was":[162],"lower":[163],"among":[164],"those":[165],"(44.4%)":[170],"than":[171],"groups":[175],"(62.5-84.2%),":[176],"although":[177],"patient":[179],"numbers":[180],"shorter":[182,224],"times":[184],"limit":[185],"generalizability":[187],"this":[189],"finding.":[190],"Each":[191],"group":[193],"showed":[194],"comparable":[195],"improvement":[196],"PANSS":[198],"total":[199],"score":[200],"baseline.":[202],"CONCLUSION:":[203],"period":[214],"days,":[217],"by":[218],"investigators'":[219],"choice.":[220],"Additional":[221],"on":[223],"conversions":[225],"may":[226],"help":[227],"clinicians":[228],"choose":[230],"switching":[232],"paradigm":[233],"that":[234],"best":[235],"meets":[236],"their":[237],"patients'":[238],"needs.":[239]},"counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2018-10-26T00:00:00"}